Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

PFIZER BORTEZOMIB POWDER FOR INJECTION 3.5MG

Approval Number

SIN15900P

Drug Name

PFIZER BORTEZOMIB POWDER FOR INJECTION 3.5MG

Product Name

PFIZER BORTEZOMIB POWDER FOR INJECTION 3.5MG

Approval Date

March 11, 2020

Registrant

PFIZER PRIVATE LIMITED

Licence Holder

PFIZER PRIVATE LIMITED

Regulatory Information

Registrant

PFIZER PRIVATE LIMITED

Licence Holder

PFIZER PRIVATE LIMITED

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, POWDER, FOR SOLUTION

Route of Administration

INTRAVENOUS, SUBCUTANEOUS

Medical Information

ATC Code

L01XX32

ATC Item Name

xl 01 xx 32

Manufacturer Information

Pharmaceutical Manufacturer

PFIZER PRIVATE LIMITED

Manufacturers

Gland Pharma Limited

Active Ingredients

Ingredient Name

Bortezomib (as a mannitol boronic ester)

Strength

3.50mg

Drug MonographBortezomib

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy